What Is It and How Does It Work?
Rezpegaldesleukin is a “biologic” treatment given by an injection under the skin twice a month. Most treatments for autoimmune hair loss (like Alopecia Areata) work by suppressing the entire immune system to stop it from attacking hair follicles. This can sometimes leave the body vulnerable to other illnesses.
Rezpegaldesleukin works differently. It is an “immune peacekeeper.” It targets a specific part of your immune system called Regulatory T-cells (or “Tregs”). These cells are responsible for telling the rest of your immune system to calm down and stop attacking your own body. By boosting these “peacekeeper” cells, the drug restores the natural balance of your scalp, allowing hair to grow back safely.
The Science and the Results
Scientists just finished a 52-week study (one full year) on 92 patients with “severe to very severe” hair loss—meaning they had lost at least 50% of their hair at the start.
The big discovery today is that the longer patients used the treatment, the better it worked. Between month 9 and month 12, a whole new group of people suddenly saw major results.
The clear results from the 52-week study:
-
Deepening Growth: About 31% of patients in the high-dose group achieved a SALT score $\le$ 20 (which means 80% or more hair coverage) during the final 16 weeks of the study.
-
Strong Performance: For the entire group, the treatment more than doubled the success rate of the fake treatment (placebo).
-
Safe Dosing: 94% of patients completed the entire year of treatment, with the most common side effect being mild redness at the injection site that went away within five days.
“The new responders in this set of patients treated out to 52 weeks reflect how the T regulatory cell mechanism can have more clinical benefit over time,” explained Dr. Jonathan Silverberg, a professor of dermatology. Dr. David Rosmarin added that this treatment delivers “meaningful hair regrowth” without the need for the heavy medical monitoring required by older drugs.
When Can You Get It?
The treatment is currently in advanced clinical trials. Because the results are so strong, the FDA has already given it “Fast Track” status to speed up the approval process. While it is not in pharmacies yet, the company plans to move into final Phase 3 testing in 2026 with the goal of making it widely available globally as soon as possible.
How you can benefit from this treatment now
While this drug is still in testing, it proves a major new theory: that “re-balancing” the immune system is a safer and more effective way to treat hair loss than “suppressing” it. This breakthrough is already helping doctors design better combinations of existing treatments, and patients can look forward to a future where they only need a simple injection twice a month to keep their hair.
